Pharmacogenomics of acetaminophen in pediatric populations: a moving target
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Acetaminophen (APAP) is widely used as an over-the-counter fever reducer and pain reliever. However, the current therapeutic use of APAP is not optimal. The inter-patient variability in both efficacy and toxicity limits the use of this drug. This is particularly an issue in pediatric populations, where tools for predicting drug efficacy and developmental toxicity are not well established. Variability in toxicity between age groups may be accounted for by differences in metabolism, transport, and the genetics behind those differences. While pharmacogenomics has been revolutionizing the paradigm of pharmacotherapy for many drugs, its application in pediatric populations faces significant challenges given the dynamic ontogenic changes in cellular and systems physiology. In this review we focused on the ontogenesis of the regulatory pathways involved in the disposition of APAP and on the variability between pediatric, adolescent, and adult patients. We also summarize important polymorphisms of the pharmacogenes associated with APAP metabolism. Pharmacogenetic studies in pediatric APAP treatment are also reviewed. We conclude that while a consensus in pharmacogenetic management of APAP in pediatric populations has not been achieved, a systems biology based strategy for comprehensively understanding the ontogenic regulatory pathway as well as the interaction between age and genetic variations are particularly necessary in order to address this question.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of cytochromes P450 in chemical toxicity and oxidative stress: studies with CYP2E1
Gonzalez, F. J. (2005) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2004.04.021 · Cited by 555 · cited 9×
“In a different study, it was found that inhibition of both CYP2E1 and CYP2A6 significantly decreased the formation of NAPQI (Gonzalez, 2005), suggesting multiple CYPs are involved in the development of APAP hepatotoxicity.”
BackgroundResultInfluentialAcetaminophen Overdose: 662 Cases With Evaluation of Oral Acetylcysteine Treatment
Rumack, B. H. (1981) · Archives of Internal Medicine · doi:10.1001/archinte.1981.00340030112020 · Cited by 350
Paracetamol and metabolite pharmacokinetics in infants
van der Marel, C. D., Anderson, B. J., van Lingen, R. A., Holford, N. H. G., Pluim, M. A. L., Jansman, F. G. A., van den Anker, J. N., & Tibboel, D. (2003) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-003-0608-0 · Cited by 98 · cited 1×
“Other investigators have demonstrated that glucuronide/sulfate ratios are 0.12 in premature neonates ( < 32 weeks), 0.28 in neonates 32–36 weeks post-conception, 0.34 in neonates 0–2 days old, 0.75 in children 3–9 years, and 1.8 in adults (Miller et al., 1976; van der Marel et al., 2003).”
BackgroundInfluential
Cited by
Rani, J., Dhull, S. B., Rose, P. K., & Kidwai, M. K. (2024) · Phytomedicine · doi:10.1016/j.phymed.2023.155142 · Cited by 91
Pickering, G., Creveaux, I., Macian, N., & Pereira, B. (2020) · Pain Medicine · doi:10.1093/pm/pnz037 · Cited by 23
Sengupta, S., Johnson, B., Seirup, M., Ardalani, H., Duffin, B., Barrett-Wilt, G. A., Stewart, R., & Thomson, J. A. (2020) · Current Research in Toxicology · doi:10.1016/j.crtox.2020.08.001 · Cited by 9
“, 2015) (Krasniak et al., 2014) between p3 (when APAP metabolism was tested) and at late passage (p7) (donor 1).”
Background
Metadata
- Authors
- Krasniak, A. E., Knipp, G. T., Svensson, C. K., & Liu, W.
- Venue
- Frontiers in Genetics
- Publisher
- Frontiers Media SA
- Published
- 2014-10-14
- Volume
- 5
- Pages
- 314-314
- ISSN
- 1664-8021 (ISSN-L)
- OpenAlex
- W2036577869
- Cited by
- 44
- References
- 3
- FWCI
- 3.50
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.